Owens & Minor, Inc. (NYSE:OMI) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 68.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 376,830 shares of the company's stock after purchasing an additional 152,999 shares during the period. JPMorgan Chase & Co. owned about 0.49% of Owens & Minor worth $5,912,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. DekaBank Deutsche Girozentrale raised its position in Owens & Minor by 76.6% during the second quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after acquiring an additional 1,356 shares during the last quarter. Quarry LP raised its position in shares of Owens & Minor by 290.1% during the 2nd quarter. Quarry LP now owns 2,099 shares of the company's stock worth $28,000 after purchasing an additional 1,561 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Owens & Minor by 4.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company's stock worth $491,000 after purchasing an additional 1,709 shares during the last quarter. Blue Trust Inc. lifted its stake in Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock valued at $44,000 after buying an additional 1,780 shares in the last quarter. Finally, Hsbc Holdings PLC grew its holdings in Owens & Minor by 10.1% during the 2nd quarter. Hsbc Holdings PLC now owns 20,639 shares of the company's stock valued at $278,000 after buying an additional 1,885 shares during the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Trading Up 0.1 %

Shares of OMI stock traded up $0.01 during trading hours on Friday, hitting $14.55. 335,621 shares of the company were exchanged, compared to its average volume of 597,893. The firm has a fifty day moving average of $13.39 and a 200 day moving average of $14.21. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 1 year low of $11.42 and a 1 year high of $28.35. The firm has a market cap of $1.12 billion, a PE ratio of -22.38, a PEG ratio of 0.39 and a beta of 0.46.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter last year, the firm posted $0.44 earnings per share. Owens & Minor's revenue was up 5.0% on a year-over-year basis. Analysts expect that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.

Insider Activity at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company's stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.59% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on OMI. UBS Group cut their price target on Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, November 5th. Citigroup cut their target price on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research note on Tuesday, November 5th. Robert W. Baird decreased their price target on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating on the stock in a research note on Tuesday, November 5th. Finally, Barclays lowered their price target on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.